{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:31:28Z","timestamp":1789396288105,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.amjcard.2025.06.015","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:52:27Z","timestamp":1751367147000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Atrial Fibrillation Burden, Risk Factors, and Prognosis in Wild-type Transthyretin Amyloidosis Cardiomyopathy"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-690X","authenticated-orcid":false,"given":"Jens Kaestel","family":"Skov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Ladefoged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Lehmann Dahl","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor Skibsted","family":"Clemmensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Hvitfeldt","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2025.06.015_bib0001","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0003","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaccao.2021.07.010","article-title":"Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Hartnett","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0004","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacep.2023.11.015","article-title":"Prevalence and Treatment of Atrial Fibrillation and Flutter in Cardiac Amyloidosis","volume":"10","author":"Haslett","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131346","article-title":"Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis","volume":"392","author":"Fumagalli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0007","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ehf2.12308","article-title":"Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience","volume":"5","author":"Mints","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0008","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial Fibrillation in Transthyretin Cardiac Amyloidosis","volume":"6","author":"Eoin","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0009","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0010","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0011","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCULATIONAHA.106.180200","article-title":"Recommendations for the Standardization and Interpretation of the Electrocardiogram","volume":"115","author":"Kligfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0012","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"Journal of the American Society of Echocardiography"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0014","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacep.2023.11.015","article-title":"Prevalence and Treatment of Atrial Fibrillation and Flutter in Cardiac Amyloidosis","volume":"10","author":"Haslett","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of Atrial Fibrillation in the 21st Century","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0016","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1002\/ehf2.14124","article-title":"Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community","volume":"9","author":"Diaz","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0017","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/ehf2.14000","article-title":"Incidence and predictors of worsening heart failure in patients with wild-type transthyretin cardiac amyloidosis","volume":"9","author":"Ladefoged","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2398735","article-title":"Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy","volume":"56","author":"Sanne B\u00f8jet","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0019","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Cardiology on behalf of the HFA of the ES of. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0020","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0021","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1038\/s41598-018-24875-1","article-title":"Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling","volume":"8","author":"Seko","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0022","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2013concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0023","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the Risk of New-Onset Atrial Fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0024","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1038\/s41598-023-32229-9","article-title":"Association of obesity with incident atrial fibrillation in Korea and the United Kingdom","volume":"13","author":"Choi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euz314","article-title":"Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis","volume":"22","author":"Donnellan","year":"2020","journal-title":"EP Europace"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0026","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaccao.2024.03.007","article-title":"Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid Cardiomyopathy","volume":"6","author":"Witteles","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0027","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.111.962688","article-title":"Atrial Fibrillation and Mortality in Heart Failure","volume":"4","author":"Chamberlain","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2025.06.015_bib0028","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1002\/ehf2.14124","article-title":"Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community","volume":"9","author":"Diaz","year":"2022","journal-title":"ESC Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925003790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925003790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:33:58Z","timestamp":1760099638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925003790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0002914925003790"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.06.015","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation Burden, Risk Factors, and Prognosis in Wild-type Transthyretin Amyloidosis Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}